Gritstone Bio (NASDAQ:GRTS) just reported results for the first quarter of 2024.
- Gritstone Bio reported earnings per share of -34 cents. This was below the analyst estimate for EPS of -33 cents.
- The company reported revenue of $1.74 million.
- This was 58.36% better than the analyst estimate for revenue of $1.10 million.